Takeda Pharmaceutical (TAK) Short-term Investments: 2018-2025

  • Takeda Pharmaceutical's Short-term Investments rose 31.82% to $134.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $134.2 million, marking a year-over-year increase of 31.82%. This contributed to the annual value of $134.4 million for FY2025, which is 28.47% up from last year.
  • Per Takeda Pharmaceutical's latest filing, its Short-term Investments stood at $134.2 million for Q1 2025, which was up 31.82% from $101.8 million recorded in Q1 2024.
  • Takeda Pharmaceutical's Short-term Investments' 5-year high stood at $345.8 million during Q1 2021, with a 5-year trough of $101.8 million in Q1 2024.
  • Its 3-year average for Short-term Investments is $129.5 million, with a median of $134.2 million in 2025.
  • Its Short-term Investments has fluctuated over the past 5 years, first soared by 137.94% in 2021, then tumbled by 37.02% in 2022.
  • Over the past 5 years, Takeda Pharmaceutical's Short-term Investments (Quarterly) stood at $345.8 million in 2021, then plummeted by 37.02% to $217.7 million in 2022, then declined by 29.96% to $152.5 million in 2023, then plummeted by 33.24% to $101.8 million in 2024, then surged by 31.82% to $134.2 million in 2025.
  • Its Short-term Investments was $134.2 million in Q1 2025, compared to $101.8 million in Q1 2024 and $152.5 million in Q1 2023.